Caffeine Citrate Oral Solution
NDC Package 72485-110-10
Package Information
Caffeine Citrate Oral Solution (caffeine citrate) solution is a medication used for the short-term treatment of a breathing problem (apnea) in premature infants. This formulation utilizes a solution delivery system. Marketed by Armas Pharmaceuticals Inc., this product is identified by NDC 72485-110 and is authorized under FDA application ANDA213202.
Identification & Billing
- RxCUI: 849928 - caffeine citrate 60 MG in 3 mL Oral Solution
- RxCUI: 849928 - caffeine citrate 20 MG/ML Oral Solution
- RxCUI: 849928 - caffeine citrate 60 MG per 3 ML Oral Solution
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 72485 - Armas Pharmaceuticals Inc.
- 72485-110 - Caffeine Citrate Oral Solution
- 72485-110-10 - 10 VIAL, SINGLE-DOSE in 1 BOX / 3 mL in 1 VIAL, SINGLE-DOSE
- 72485-110 - Caffeine Citrate Oral Solution
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 72485-110-10 identifies a specific commercial package of 10 vial, single-dose in 1 box / 3 ml in 1 vial, single-dose of Caffeine Citrate Oral Solution, a human prescription drug labeled by Armas Pharmaceuticals Inc.. This solution is formulated for oral use and contains caffeine citrate as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Armas Pharmaceuticals Inc. on March 01, 2020. The current certification is valid through December 31, 2026.
What are the primary indications for this medication?
This medication is used for the short-term treatment of a breathing problem (apnea) in premature infants. Caffeine blocks certain proteins (adenosine receptors) which lead to improved breathing in these infants.
How is this Armas Pharmaceuticals Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 72485011010. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.